Intramedullary spinal cord metastasis of lung cancer presenting with acute urinary retention: a case report by SEN, Cenk Ahmet et al.
   CASE REPORT / OLGU SUNUMU
192
ABSTRACT
Intramedullary spinal cord metastasis is a rare entity. In this 
case report , we described an 82-year-old male patient with lung 
cancer who developed acute urinary retention during palliative 
radiotherapy for painful rib metastases.  Left lower limb paresis 
occurred subsequently. Magnetic resonance imaging (MRI) scan 
revealed intramedullary spinal cord metastasis at the 11th-12th 
thoracic spine level. We decided to give steroid treatment and 
apply palliative radiotherapy.  Spinal cord compression is generally 
seen due to vertebral metastases and compression fractures. 
Intramedullary spinal cord metastasis is a rare entity with only case 
reports in the literature. We aim to draw attention to this rare entity 
and increase awareness among physicians.
Keywords:  Intramedullary spinal cord metastasis, Acute urinary 
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ÖZ
İntramedullar spinal kord metastazı nadir görülen bir durumdur. 
Ağrılı kostal metastaza yönelik radyoterapi uygulanan 82 yaşındaki 
akciğer kanserli bir olguda akut üriner retansiyon ve ardından sol 
alt ekstremite parezisi gelişti. Manyetik rezonans görüntüleme 
(MRG)’de torakal 11-12 vertebral aralığında intramedullar spinal 
kord metastazı saptanan hastaya steroid tedavi ve radyoterapi 
uygulandı. Spinal kord basıları genellikle vertebra metastazları ve 
kompresyon fraktürlerine bağlı olarak gelişir. Intramedullar spinal 
kord metastazları ise nadirdir ve literatürde olgu sunumları şeklinde 
raporlanmıştır. Nadir görülen bu olguyu klinik değerlendirme 
amacıyla raporladık.
Anahtar kelimeler: İntramedullar spinal kord metastazı, Akut 
üriner retansiyon, Akciğer kanseri
Introduction 
Intramedullary spinal cord metastasis (ISCM) is a rare entity 
seen in the course of malignant tumors. In autopsy series, the 
incidence is reported as 2%  in patients with malignancies 
[1,2]. Due to the low incidence  of treated cases, standard 
treatment methods are still to be defined. Early diagnosis of 
the ISCM and microsurgical operations can slightly improve 
the prognosis and neurological deficit, but surgical resection 
usually  is not recommended for  these patients [3]. Patients 
with ISCM are generally in poor performance status, and 
have visceral metastases. Thus,  radiotherapy and steroid 
therapy are still the main treatment options.  However, 
clinical benefits are limited [4]. The clinical course is 
rapidly progressive with permanent neurological morbidity, 
and poor survival [5].
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Case Report
An 82-year-old male admitted to radiation oncology 
department due to severe pain of the right chest wall. He had 
a one-pack-a-day history of smoking for  more than 50 years. 
His  Eastern Cooperative Oncology Group (ECOG) Scale 
Performance Status was 2. The source of the pain was a 3-cm 
metastatic lesion located between the 3rd, and the 4th ribs seen 
in the chest computed tomography. There was a 5 cm mass in 
the right upper lung. We planned stereotactic radiosurgery to 
the painful intercostal lesion. His pain reduced  on  the 2nd 
day of treatment. A sudden urinary retention and abdominal 
pain occurred. Physical examination and abdominal 
ultrasonography showed urinary retention with greatly 
enlarged bladder. Thoracic spine magnetic resonance imaging 
(MRI) demonstrated an intramedullary spinal cord lesion at 
the 11th-12th thoracic spine level (Figure 1). Craniocaudal 
dimension of the lesion was about 2 cm. Brain MRI was 
normal. Subsequently numbness and disability occurred at 
his left lower extremity. Neurological examination showed 
monoparesis of the left lower extremity (2/5). We treated 
the patient with immediate corticosteroid treatment and 
radiotherapy. Total radiotherapy dose was 30 Gy given in 10 
fractions with a daily fraction dose of 3 Gy.  Urinary catheter 
was removed on the 15th day after radiotherapy. Urinary 
retention did not occur again, but there was no regression in 
his left lower extremity paralysis. The patient died due to his 
cancer after 3 months from the diagnosis. 
Figure 1. Sagittal T1 and T2-w, post contrast sagittal and axial 
thoracic spine MRI images demonstrated a contrast enhanced 
intramedullary spinal cord lesion with a diameter of 20x7 mm, at 
the 11th-12th thoracic spine level.
Discussion
ISCM is a rare entity, accounting for only 0.1% - 0.4% of all 
cancer patients [6]. However,  the incidence is on the rise due 
to the improved survival of cancer patients [7]. Most of the 
patients with ISCM have brain and systemic metastases at 
the time of diagnosis [8].  Spreading route to intramedullary 
spinal region might occur in 3 ways; hematogenous spread, 
direct invasion by meningeal tumors and direct invasion 
from contiguous structures . Overall survival is very poor. 
Symptoms may change from minor to major neurological 
symptoms. Our patient had monoparesis of the left lower 
extremity (2/5). Mortality rate is 80% during the first three to 
four months following the occurrence of the first symptom. 
Death occurs due to complications of neurological damage 
and progressive cancer. Our patient died due to his cancer 
after 3 months from the diagnosis. 
Willis was the first to review the pathological evaluation 
of the subject  [9]. In major clinical series  dating back to 
the   1972’s,   9 patients were reported  [10]. The largest 
clinical series with 40 patients were  reported in 1996  [11]. 
In the PubMed search, a total of 248 patients with ISCM 
were identified (Table I).
Table I. The cases identified in the PubMed search
Gadolinium-enhanced MRI shows high sensitivity and 
has become the gold standard in diagnosis of all spinal canal 
lesions [12]. PET-CT has a sensitivity of 96% in detecting 
spinal metastasis [13].
Radiotherapy is the standard treatment option. Intensity 
modulated radiation therapy, cyberknife  and tomotherapy 
are modern radiotherapy techniques, but no significant data 
support their routine use. In selected cases, microsurgical 
techniques might be effective. Microsurgical removal of 
ISCM can improve the quality of life in early diagnosis 
in selected patients. Aggressive surgical treatment with 
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postoperative adjuvant radiotherapy and chemotherapy 
might prolong survival.  
Possibility of intramedullary metastasis should be 
considered in case of acute urinary retention in the lack of 
vertebral metastasis.
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